Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Clinical trial NCT05919108 · RECRUITING

Trial details

NCT number: NCT05919108
Sponsor: Vanderbilt-Ingram Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anatomic Stage I Breast Cancer Anatomic Stage II Breast Cancer Anatomic Stage III Breast Cancer Invasive Breast Lobular Carcinoma

Start date: 2024-05-30
Primary completion: 2030-04-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.